Kentucky program
Deadlines for a plan’s treatment decision
Kentucky law sets deadlines for certain treatment approvals and drug step-therapy exceptions.
What it is
Kentucky law sets deadlines for certain treatment approvals and drug step-therapy exceptions.
A complete request starts the relevant decision clock. The clinic can document when the plan received everything it needs. Drug step-therapy exceptions follow a separate rule from ordinary treatment review.
Eligibility rules
- Insurers covering Kentucky citizens under a health benefit plan; the step-therapy section uses its own definition of state-regulated prescription-drug plans.
- You must live in Kentucky.
What you get
- A treatment decision within 24 hours when urgent, or five days otherwise.
- A decision on a complete step-therapy exception within 48 hours.
Amounts and limits
- Hours for an urgent utilisation review decision after all necessary information: 24 hours.
- Days for a nonurgent decision after all necessary information: 5 days.
- Hours for a complete step-therapy exception or internal appeal: 48 hours.
If you decide to apply
- Ask the clinic to confirm when the plan received the complete request and which deadline applies.
- If a response is late, ask the insurer or Department of Insurance to review the dates.
Kentucky prior-authorization clocks: 800-595-6053 · Official page ↗
If you decide to apply
- The decision comes from the plan or its review agent.
Good to know
A missed deadline can matter for ordinary treatment review as well as drug exceptions. The clinic and Department of Insurance can check whether the law treats the request as approved.
Other details
- Ordinary utilization review uses 24 hours for urgent decisions and five days otherwise after necessary information arrives. Missing the required decision and written notice can trigger deemed authorization, subject to the statute’s beyond-control exception.
- The plan must skip a "try this cheaper drug first" step when the doctor says the cheaper drug would harm your child, would not work, has already failed, or your child is stable on the prescribed one.
- The step-therapy statute, effective July 15, 2024, gives 48 hours for complete exception requests or internal appeals and requires timely notice of missing information. A clinically ineffective trial is generally limited to 30 days, with a limited additional seven-day provision.
Official sources
- Prior authorization: step grounds and missed-deadline remedies
- Prior authorization: step grounds and missed-deadline remedies
- Prior authorization: step grounds and missed-deadline remedies
- Prior authorization: step grounds and missed-deadline remedies
- Kentucky Department of Insurance — Consumer resources
- Prior authorization: step grounds and missed-deadline remedies
- Kentucky private-plan insurance protections and scope
- Kentucky private-plan insurance protections and scope
- Kentucky private-plan insurance protections and scope
- Kentucky private-plan insurance protections and scope
- Kentucky private-plan insurance protections and scope
- Kentucky private-plan insurance protections and scope
“If a treatment request is delayed, what would these deadlines help us do, what are their limits, and could you help us seek a decision?”
Why I’m asking: I want to understand whether a delayed treatment decision has a deadline we can use.
More background and detailed requirements
Additional program information and published rules
Who does what
The three parts, side by side. The agency decides; nobody on this page does.
You
Ask what is outstanding in writing and hold the plan to the date.
Your social worker
The clinic sends the clinical information the plan needs.
The care team
The oncologist can name the step-therapy route that fits: contraindication, expected ineffectiveness, prior failure or being stable on the chosen drug.
- Who decides
- The plan or its review agent.
- Ask the care team
- “Can you confirm in writing what the plan still needs, and which step-therapy exception route applies? I want the decision date on record.”
How to apply
First step: Ask the plan in writing what information is outstanding, and note the date the decision becomes due.
- Ask the plan in writing what is still missing, so the clock starts.
- If the plan wants a different drug first, ask for a step-therapy exception and name the route.
- Put the deadline date in your phone and call on it.
Official application / program page ↗
Where it starts: Ask the plan in writing what information is still outstanding, then hold it to the clock. The Department of Insurance takes complaints on 800-595-6053.
What to gather
- The request date and the reference number
- The plan's letters
- The oncologist's note on why the timing matters
How long: 24 hours urgent, five days otherwise, 48 hours for a step-therapy exception.
What a yes looks like
An authorisation number and the dates it covers.
What a no looks like, and the next move
Ask for the denial in writing and start the plan's internal appeal the same day; the outside review follows it.
Watch out
- The clock starts when the plan has everything it needs. Ask in writing what is missing so the clock starts and there is a record.
- The gold-card rule that lets a doctor skip prior authorisation does not begin until 2028, and it leaves out prescription drugs.
The numbers and the rules
The arcane layer, kept on purpose. Checked September 11, 2026.
What it is worth
24 hours for an urgent decision, five days otherwise, and 48 hours for a step-therapy exception, with a missed deadline counting as a grant.
- $24 — Hours for an urgent utilisation review decision after all necessary information
- $5 — Days for a nonurgent decision after all necessary information
- $48 — Hours for a complete step-therapy exception or internal appeal
Legal protection: Missed deadlines can trigger remedies under both ordinary utilization review and step therapy, with their separate conditions and exceptions. · Four written routes to a step-therapy exception, including prior failure and being stable on the chosen drug
What it costs the family: Nothing.
The eligibility facts, as published
- Plan type
- insurers covering Kentucky citizens under a health benefit plan; the step-therapy section uses its own definition of state-regulated prescription-drug plans
- Residency
- Kentucky
The trap: The clocks run from the moment the plan has all the information it needs, not from the day the request was sent. Ask in writing what is still missing, so the clock starts and there is a record that it did.
Where I read this
- KRS 304.17A-607 — Utilization review duties — Kentucky Legislature, read September 10, 2026
- KRS 304.17A-163 — Step therapy exceptions — Kentucky Legislature, read September 10, 2026
- KRS 304.17A-606 — Prior authorization exemption program — Kentucky Legislature, read September 10, 2026
- KRS 304.17A-603 — Application of utilization review provisions — Kentucky Legislature, read September 10, 2026
- Kentucky Department of Insurance — Consumer resources — Kentucky Department of Insurance, read September 10, 2026
